Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Borola is a leading Bulgarian healthcare company founded in 1996 that specializes in the development and marketing of innovative pharmaceutical and nutraceutical products. The company focuses on evidence-based natural health solutions and operates across various therapeutic areas, including immunology, dermatology, women's health, and gastroenterology. Borola is well-known for its established brands such as Imunobor, GinGira, Feminorm, and Entyrol, which are widely distributed in the Bulgarian and regional European markets. Its business model integrates research, registration, and commercialization to provide comprehensive healthcare solutions. Borola maintains a strong presence through its specialized health centers and a robust network of medical representatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Borola.